In February 2023, medac Nordics announced a Scientific Grant in Hematology to be awarded to research projects within stem cell transplantation.
In total 10 applications were submitted with representation from all Nordic countries. On the 12th of October, the Scientific Grant committee consisting of four independent Nordic experts in Hematology, gathered to discuss and select one to two projects to be awarded the grant.
The Scientific committee awarded the medac Grant to:
- “Allogeneic hematopoietic stem cell transplantation for TP53 mutated myeloid neoplasms”
Dr Anders Myhre, Oslo University Hospital, Norway
- “The tumor burden as a determinant of the outcome of allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis – a need for more intensive induction therapy?”
Dr Morten Holmström, Rigshospitalet, Copenhagen, Denmark
medac wishes all the researchers every success with their projects, also to those who were not selected this time.